Alzamend Neuro, Inc. 10-K filing
Filed 2026-07-22 · Report date 2026-04-30 · 2026 FY
Filing metadata
- Accession number
- 0001214659-26-008832
- Form type
- 10-K
- CIK
- 0001677077
- Primary document
- https://www.sec.gov/Archives/edgar/data/1677077/000121465926008832/az72426110k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Alzamend Neuro, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-8.8M | - | - |
| Net Income | $-8.8M | - | - |
| Eps Basic | -2.63 | - | - |
| Eps Diluted | -2.63 | - | - |
| Cash And Equivalents | $710,689 | - | - |
| Total Assets | $2.1M | - | - |
| Total Liabilities | $1.3M | - | - |
| Shareholders Equity | $733,211 | - | - |
| Operating Cash Flow | $-8.1M | - | - |